37.64
Omnicell Inc stock is traded at $37.64, with a volume of 686.10K.
It is up +1.37% in the last 24 hours and down -19.37% over the past month.
Omnicell Inc provides automation and business analytics software for healthcare providers. The company is engaged in transforming the pharmacy and nursing care delivery model. The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks and drive improved clinical, operational, and financial outcomes across all care settings. The company derives the majority of its revenue from the United States.
See More
Previous Close:
$37.13
Open:
$37.41
24h Volume:
686.10K
Relative Volume:
0.97
Market Cap:
$1.72B
Revenue:
$1.23B
Net Income/Loss:
$20.43M
P/E Ratio:
85.33
EPS:
0.4411
Net Cash Flow:
$95.39M
1W Performance:
+4.09%
1M Performance:
-19.37%
6M Performance:
+3.12%
1Y Performance:
+20.10%
Omnicell Inc Stock (OMCL) Company Profile
Name
Omnicell Inc
Sector
Industry
Phone
(877) 415-9990
Address
4220 NORTH FREEWAY, FORT WORTH
Compare OMCL vs VEEV, BTSG, TEM, HQY, TXG
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
OMCL
Omnicell Inc
|
37.64 | 1.69B | 1.23B | 20.43M | 95.39M | 0.4411 |
|
VEEV
Veeva Systems Inc
|
252.64 | 39.23B | 3.32B | 941.65M | 1.64B | 5.6161 |
|
BTSG
Brightspring Health Services Inc
|
60.23 | 11.81B | 13.65B | 169.86M | 412.12M | 1.0758 |
|
TEM
Tempus Ai Inc
|
54.29 | 9.85B | 1.36B | -302.91M | -219.93M | -1.7182 |
|
HQY
Healthequity Inc
|
105.59 | 8.82B | 1.34B | 230.70M | 440.96M | 2.6695 |
|
TXG
10 X Genomics Inc
|
58.15 | 7.52B | 638.78M | -22.66M | 122.18M | -0.1744 |
Omnicell Inc Stock (OMCL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-04-26 | Upgrade | BofA Securities | Neutral → Buy |
| Jan-08-26 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| May-14-25 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Oct-31-24 | Downgrade | BofA Securities | Buy → Neutral |
| Aug-02-24 | Upgrade | Barclays | Underweight → Equal Weight |
| Jan-03-24 | Initiated | Barclays | Underweight |
| Nov-03-23 | Downgrade | BTIG Research | Buy → Neutral |
| Nov-03-23 | Upgrade | Piper Sandler | Neutral → Overweight |
| Nov-03-23 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Oct-11-23 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Sep-26-23 | Reiterated | Wells Fargo | Underweight |
| Aug-02-23 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jul-20-23 | Downgrade | Wells Fargo | Overweight → Underweight |
| Feb-27-23 | Upgrade | The Benchmark Company | Hold → Buy |
| Nov-03-22 | Downgrade | The Benchmark Company | Buy → Hold |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Overweight |
| Sep-09-22 | Initiated | BofA Securities | Buy |
| Jul-15-22 | Initiated | SVB Leerink | Mkt Perform |
| Dec-06-21 | Resumed | Wells Fargo | Overweight |
| Jun-09-21 | Initiated | JP Morgan | Neutral |
| May-24-21 | Initiated | BTIG Research | Buy |
| Feb-02-21 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-08-20 | Initiated | Berenberg | Buy |
| Dec-03-20 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Jul-07-20 | Initiated | Stephens | Overweight |
| Feb-07-20 | Reiterated | Dougherty & Company | Buy |
| Nov-21-19 | Reiterated | Dougherty & Company | Buy |
| Jul-26-19 | Upgrade | Craig Hallum | Hold → Buy |
| Mar-07-19 | Reiterated | Dougherty & Company | Buy |
| Jun-29-18 | Resumed | The Benchmark Company | Buy |
| Sep-05-17 | Reiterated | The Benchmark Company | Buy |
| Jul-28-17 | Reiterated | Dougherty & Company | Buy |
| Apr-21-17 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Jan-19-17 | Initiated | Dougherty & Company | Buy |
| Dec-06-16 | Reiterated | The Benchmark Company | Buy |
| Jul-07-16 | Reiterated | FBR Capital | Outperform |
| Mar-21-16 | Reiterated | Topeka Capital Markets | Buy |
| Jan-07-16 | Initiated | The Benchmark Company | Buy |
| Nov-16-15 | Reiterated | Topeka Capital Markets | Buy |
| Oct-30-15 | Reiterated | FBR Capital | Outperform |
| Sep-28-15 | Upgrade | Sidoti | Neutral → Buy |
| Jul-31-15 | Reiterated | Topeka Capital Markets | Buy |
View All
Omnicell Inc Stock (OMCL) Latest News
Omnicell Raises 2026 EPS Outlook as Memory Costs Pressure Margins - Yahoo Finance Singapore
Omnicell, Inc. (OMCL) Stock Forecasts - Yahoo Finance
OMCL Falls 20.1% in a Month as Booking and Margin Risks Build - Yahoo Finance
Quantinno Capital Management LP Has $1.92 Million Position in Omnicell, Inc. $OMCL - MarketBeat
(OMCL) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Millennium reports 3.8% Omnicell (OMCL) stake in amended 13G filing - Stock Titan
Omnicell Inc (OMCL) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Does Omnicell’s Profit Rebound And Higher 2026 Outlook Change The Bull Case For OMCL? - simplywall.st
First Trust Advisors LP Has $2.85 Million Stake in Omnicell, Inc. $OMCL - MarketBeat
Royal Bank of Canada Sells 78,803 Shares of Omnicell, Inc. $OMCL - MarketBeat
OMNICELL, INC. 2026: Revenue $312.21M, EPS $0.52— 10-Q Summary - TradingView
Omnicell, Inc. (NASDAQ: OMCL) returns to profit with Q2 2026 growth - Stock Titan
Omnicell, Inc. (OMCL) - directorstalkinterviews.com
Omnicell (OMCL) Is Down 12.5% After Raising 2026 Revenue Outlook And Returning To Profitability - Yahoo! Finance Canada
Weekly Recap: Omnicell, Inc. Q3/2026 revenue and analyst price target - TradingView
Piper Sandler Maintains Omnicell(OMCL.US) With Buy Rating, Cuts Target Price to $45 - Moomoo
Omnicell (OMCL) Stock May Be 42% Below Fair Value On Weak Guidance - Yahoo Finance
OMNICELL INC : PIPER SANDLER CUTS TARGET PRICE TO $45 FROM $55 - Bitget
Enterprise value to revenue forward of Omnicell, Inc. – NASDAQ:OMCL - tradingview.com
BofA Securities Maintains Omnicell(OMCL.US) With Buy Rating - moomoo.com
Wells Fargo Maintains Omnicell(OMCL.US) With Buy Rating, Cuts Target Price to $50 - Moomoo
KeyBanc Maintains Omnicell(OMCL.US) With Buy Rating, Cuts Target Price to $65 - Moomoo
Omnicell Inc (OMCL) (Q2 2026) Earnings Call Highlights: Strong P - GuruFocus
Omnicell (OMCL) Stock Trades Down, Here Is Why - TradingView
Transcript : Omnicell, Inc., Q2 2026 Earnings Call, Jul 30, 2026 - marketscreener.com
Omnicell, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Omnicell’s (NASDAQ:OMCL) Q2 CY2026: Beats On Revenue But Stock Drops On Weak Guidance - The Globe and Mail
(OMCL) Omnicell, Inc. Expects Q3 Adjusted EPS Range $0.35$0.43 - marketscreener.com
Omnicell reports Q2 revenue $312.2M, GAAP net income $24.3M and non-GAAP EPS $0.94 - tradingview.com
Omnicell: Q2 Earnings Snapshot - KTVB
Omnicell Q2 adjusted EPS beats estimates, but tightens 2026 revenue guidance - TradingView
Omnicell earnings on deck: Can Titan XT launch sustain momentum? By Investing.com - Investing.com Nigeria
Omnicell (OMCL) Reports Q2: Everything You Need To Know Ahead Of Earnings - TradingView
Omnicell, Inc. (NASDAQ:OMCL) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
TradingKey - TradingKey
OMCL|Omnicell Inc|Price:41.000|Chg%:+1.140 - TradingKey
Omnicell (OMCL) Stock Forum and Discussion - Moomoo
Omnicell Inc (OMCL) Valuation: PE, PB & Fair Value Analysis - TradingKey
Omnicell Inc (OMCL) Institutional Confidence - TradingKey
Omnicell Inc (OMCL) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Omnicell, Inc. Revenue Breakdown – NASDAQ:OMCL - TradingView
Omnicell Inc (OMCL) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Omnicell Inc (OMCL) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Omnicell Inc (OMCL) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
OMCL|Omnicell Inc|Price:39.845|Chg%:-1.015 - TradingKey
Omnicell Inc (OMCL) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Price to earnings forward of Omnicell, Inc. – BX:OC9 - TradingView
Price to book forward of Omnicell, Inc. – NASDAQ:OMCL - TradingView
Price to book forward of Omnicell, Inc. – BX:OC9 - TradingView
Omnicell to report Q2 earnings: OmniSphere in focus - MSN
Omnicell to Report Q2 Earnings: OmniSphere in Focus - Yahoo Finance
Omnicell Inc Stock (OMCL) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):